meda ab-a shs (MEDAA:Stockholm)
Former Director, Meda AB
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Lennart Perlhagen served as Chief Executive Officer for Scandinavia and UK for Pfizer where Mr. Perlhagen gained extensive experience in oncology through the launch of the chemotherapy agent doxorubicin (Adriamycin). Mr. Perlhagen helped lead the commercial launch of omeprazole (Losec/ Prilosec), which became the best selling pharmaceutical product in the world for AstroZeneca AB where he served as Regional Director for South Europe. He founded Meda AB. He has been a ...
Pipers väg 2APhone: 46 86 30 19 00
Solna, Stockholm County 170 73
Fax: 46 86 30 19 50
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jean-Paul Clozel M.D.||Founder, Chief Executive Officer, Member of Management Board and Director|
|Marc M.P. de Garidel||Chairman, Chief Executive Officer and Member of Strategic Committee|
|Giovanni Recordati||Chairman, Chief Executive Officer and General Manager|
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee|
|Timo Lappalainen M.Sc. (Ind. Eng.)||Chairman of the Executive Management Board, Chief Executive Officer and President|
|€1.4M||Compensation as of Fiscal Year 2013.|